Author: Nicole Gulinazzo

Insights from Attending the 2022 Society of Hematologic Oncology (SOHO) Annual Meeting

Saad Z. Usmani, MD, MBA, FACP, Memorial Sloan Kettering Cancer Center, New York, NY

What’s New in the Treatment of BPDCN?

Naveen Pemmaraju, MD, The University of Texas MD Anderson Cancer Center, Houston, TX

Mastocytosis: Insight into a Rare Blood Cancer

Jason Gotlib, MD, Stanford University School of Medicine, Palo Alto, CA

The Role of Genomics in Treating Blood Cancers

Rafael Fonseca, MD, Mayo Clinic, Phoenix, AZ

Insights into Pediatric Survivorship for the HCP

Kevin C. Oeffinger, MD, FASCO, Duke University Medical Center, Durham, NC

PedAL: First-of-Its-Kind Global Master Clinical Trial for Pediatric Acute Leukemia

Gwen L. Nichols, MD, The Leukemia & Lymphoma Society, Rye Brook, NY

Scroll to Top